EKIMAS Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASNB research report →
About the company
Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction.
- CEO
- Henrik Rouf
- IPO
- 1996
- Employees
- 11
- HQ
- Las Vegas, NV, US
Price Chart
- Market Cap
- $4.83M
- P/E
- -17.95
- P/S
- 0.00
- P/B
- 0.70
- EV/EBITDA
- -11.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -7.18%
- ROIC
- -5.38%
- Revenue
- $5.00K · 0.00%
- Net Income
- $-2,901,321 · 0.00%
- EPS
- $-0.32 · 0.00%
- Op Income
- $-2,919,365
- FCF YoY
- 0.00%
- 52W High
- $1.70
- 52W Low
- $0.55
- 50D MA
- $0.80
- 200D MA
- $0.92
- Beta
- -0.58
- Avg Volume
- 2.06K
Get TickerSpark's AI analysis on ASNB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ASNB coverage
Recent articles, reports, and earnings notes.
No research on ASNB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ASNB report →Similar companies
Peers in the same neighborhood.